Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02105311
Other study ID # EC57-020-02-1
Secondary ID
Status Completed
Phase Phase 4
First received March 28, 2014
Last updated August 4, 2016
Start date March 2014
Est. completion date February 2016

Study information

Verified date August 2016
Source Prince of Songkla University
Contact n/a
Is FDA regulated No
Health authority Thailand: Research Institute for Health Sciences
Study type Interventional

Clinical Trial Summary

The investigators conduct this study to access the effect of selective laser trabeculoplasty on 24-hour circadian tension curves of patients with open-angle glaucoma, normal tension glaucoma and ocular hypertension. This treatment effect is compared with that of the prostaglandin analogue, travoprost.


Description:

Selective laser trabeculoplasty is an effective treatment for lowering intraocular pressure in patients with open-angle glaucoma. Clinical evaluations of its effectiveness in individual patients usually are derived from baseline and post-laser measurements of intraocular pressure during office hours in the sitting position. Only a few studies have examined the efficacy of laser trabeculoplasty beyond office hours. Although the 24-hour effect of laser trabeculoplasty has been studied ,the study was conducted before the use of these new and more potent intraocular pressure lowering drugs. So it doesn't have any study to determine the effect of selective laser trabeculoplasty and travoprost to reduce the diurnal and nocturnal variation of Iintraocular pressure.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date February 2016
Est. primary completion date February 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age > 18 year-old

- Patients who were diagnosed as primary open-angle glaucoma, normal tension glaucoma, and ocular hypertension either newly diagnosed or currently on medical therapy.

- Agree to participate in the study, accept to be randomized to receive treatment, and willing to sign an informed consent

Exclusion Criteria:

Related to the severity of disease and visual acuity status

- Advance glaucoma in the study eye

- Have a very high intraocular pressure that need immediate treatment to prevent retinal vein occlusion (intraocular pressure >30 mmHg)

- Currently on maximal tolerated medical treatment and unable to control intraocular pressure

- Currently on oral carbonic anhydrase inhibitor for intraocular pressure control

- Single eye, the other eye blind from any cause

Related to surgical procedures

- Prior laser trabeculoplasty

- Prior glaucoma surgery

- Prior retinal surgery

- Underwent less than 3-month cataract extraction

- Potential need for other ocular surgery within the 2-3-month follow-up period since enrollment Related to underlying and ocular history

- History of diabetic retinopathy staged as severe non-proliferative or worse

- Narrow iridocorneal angle

- Ocular condition precluding visualization of trabecular meshwork

- Recently have ocular inflammation of any cause

- Previous history of ocular trauma

- Pregnant or breast-feeding women Related to the difficulty of having reliable measurements

- History of refractive surgery or any keratoplastic procedure

- Corneal opacities or diseases making no suitable tonometry

- Subjects with having poor or eccentric fixation or nystagmus

- Excessive eye squeezing

- Unable to lay down for measuring intraocular pressure in supine position during the night time

- Unable to have intraocular pressure checked every 2-hour such as have complicated underlying diseases or having sleep deprivation Related to allergy

- Known allergy to topical anesthesia

- Known allergy to fluorescein solution

- Known allergy to travoprost Related to compliance

- Impairment preventing adequate understanding to sign an informed consent

- Subject has demonstrated potential for non-compliance with the study protocol

- Unwilling to be randomized to receive treatment

- Unwilling to be washed out from currently treated drug(s).

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Selective laser trabeculoplasty
Selective laser trabeculoplasty platform The Lumenis Selecta® Duetâ„¢ (Lumenis Ltd., Yokneam, Israel)
Drug:
Travoprost
Travoprost benzalkonium-free ophthalmic solution (40 microgram/ml) (Alcon Laboratories, Inc., Fort Worth, TX, USA)

Locations

Country Name City State
Thailand Songklanagarind Hospital Hatyai Songkhla

Sponsors (1)

Lead Sponsor Collaborator
Prince of Songkla University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of circadian intraocular pressure intraocular pressure values measured during daytime and nighttime, compare between selective laser trabeculoplasty and travoprost (include pre- and post-treatment intraocular pressure values) Six weeks after recieving treatment No
Secondary Position related intraocular pressure Intraocular pressure different when measuring in the sitting and supine position (include pre- and post-treatment intraocular pressure values Six weeks after the treatments No
Secondary Ocular surface disease Using the glaucoma symptom scale-10 (GSS-10) and ocular surface disease questionnaire for evaluation Six weeks after the treatments Yes
See also
  Status Clinical Trial Phase
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT03016234 - IOP Changes With Different Anesthetic Agents During Laparoscopic Colorectal Surgery N/A
Completed NCT04863209 - Effect of Osteopathic Techiniques on Intraocular Pressure N/A
Completed NCT03139708 - The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients Phase 1
Completed NCT02646033 - Quantitative Rise in Intraocular Pressure in Steep Trendelenburg Position
Recruiting NCT02697825 - Intraocular Pressure Versus Optic Nerve Sheath Diameter N/A
Completed NCT02985567 - An Observational Study of the Use of Chloral Hydrate for Ophthalmic Procedures in Children N/A
Withdrawn NCT00837226 - Effects of Weight Loss From Bariatric Surgery on Intraocular Pressure (IOP) N/A
Completed NCT02136589 - Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes Phase 4
Completed NCT03123614 - Loteprednol vs. Prednisolone and Fluorometholone Phase 4
Completed NCT05763056 - Effects of Intubation on Intra-ocular Pressure and Optic Nerve Sheath Diameter N/A
Completed NCT03359200 - Analysis of the Microbiota in Goldmann Applanation Tonometers at a Reference Service in Goiânia N/A
Completed NCT02816905 - Ocular-hypertensive Response to Topical Steroids in Children After Bilateral Strabismus Surgery Phase 4
Withdrawn NCT02558309 - Optic Nerve Head Quantification While Reducing Elevated Intracranial Pressure N/A
Completed NCT01786954 - iCare vs Tonopen vs Goldmann Applanation Post-vitrectomy Surgery N/A
Completed NCT00552019 - Intraocular Pressure (IOP) Assessed by Dynamic Contour Tonometer (DCT) and Goldman Applanation Tonometry (GAT) N/A
Completed NCT00428740 - Long-Term IOP Fluctuation and VF Progression After Triple Procedure N/A
Completed NCT04360369 - Comparison of Intraocular Pressure Measurements Between Reichert Tono-Vera Tonometer and Goldmann Tonometry N/A
Completed NCT04521140 - Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery Phase 4
Completed NCT05167773 - Clinical Study of the Topcon Tonometer TRK-3